Contributors |
|
xiii | |
Preface |
|
xix | |
Volumes in Series |
|
xxi | |
|
Section I New Approaches to Studying UPR and Cell Stress |
|
|
1 | (380) |
|
1 CFTR Expression Regulation by the Unfolded Protein Response |
|
|
3 | (22) |
|
|
|
|
|
|
|
|
4 | (2) |
|
|
6 | (16) |
|
|
22 | (1) |
|
|
22 | (3) |
|
2 GRP78/BiP Chapter: Modulation of GRP78/BiP in Altering Sensitivity to Chemotherapy |
|
|
25 | (12) |
|
|
|
26 | (1) |
|
2 Measurement of ER Stress In Vitro and In Vivo |
|
|
27 | (9) |
|
|
36 | (1) |
|
|
36 | (1) |
|
3 Targeting the Unfolded Protein Response in Cancer Therapy |
|
|
37 | (20) |
|
|
|
|
|
38 | (1) |
|
|
38 | (2) |
|
|
40 | (10) |
|
4 Combination of EGF-SubA with Other UPR-Targeting Drugs |
|
|
50 | (4) |
|
|
54 | (1) |
|
|
54 | (3) |
|
4 Large-Scale Analysis of UPR-Mediated Apoptosis in Human Cells |
|
|
57 | (16) |
|
|
|
|
|
|
|
58 | (2) |
|
2 Monitoring Proliferation and Caspase Activation Following UPR Activation |
|
|
60 | (1) |
|
3 Monitoring the Expression of UPR and Cell Death Target Genes |
|
|
61 | (7) |
|
4 DNA Fragmentation Analysis |
|
|
68 | (1) |
|
|
69 | (1) |
|
|
69 | (4) |
|
5 Quantitative Analysis of Amino Acid Oxidation Markers by Tandem Mass Spectrometry |
|
|
73 | (18) |
|
Anuradha Vivekanandan-Giri |
|
|
|
|
|
75 | (1) |
|
2 Experimental Procedures |
|
|
76 | (6) |
|
|
82 | (4) |
|
|
86 | (1) |
|
|
86 | (1) |
|
|
87 | (4) |
|
6 Animal Models in the Study of the Unfolded Protein Response |
|
|
91 | (20) |
|
|
|
|
92 | (1) |
|
2 Activating Transcription Factor 6 |
|
|
93 | (1) |
|
3 IRE1/X-Box-Binding Protein-1 |
|
|
94 | (3) |
|
|
97 | (1) |
|
|
98 | (1) |
|
|
99 | (1) |
|
|
100 | (1) |
|
|
101 | (1) |
|
|
102 | (1) |
|
10 Transgenic Mouse Models for Monitoring ER Stress |
|
|
102 | (1) |
|
11 UPR and Lipid Metabollsm |
|
|
103 | (1) |
|
12 UPR, Hypoxia, and Cancer |
|
|
104 | (1) |
|
13 UPR and Inflammatory-Mediated Demyelination |
|
|
105 | (1) |
|
|
105 | (1) |
|
|
106 | (5) |
|
7 Measurement of Fluoride-Induced Endoplasmic Reticulum Stress Using Gaussia Luciferase |
|
|
111 | (16) |
|
|
|
|
|
|
112 | (2) |
|
2 Properties of Gaussia Luciferase |
|
|
114 | (1) |
|
|
115 | (3) |
|
|
118 | (5) |
|
|
123 | (1) |
|
|
124 | (3) |
|
8 Analysis of Nelfinavir-Induced Endoplasmic Reticulum Stress |
|
|
127 | (16) |
|
|
|
128 | (1) |
|
|
129 | (1) |
|
|
129 | (1) |
|
4 Analysis of Nelfinavir-Induced ER Stress |
|
|
130 | (4) |
|
|
134 | (1) |
|
|
135 | (6) |
|
|
141 | (1) |
|
|
142 | (1) |
|
|
142 | (1) |
|
9 Using Temporal Genetic Switches to Synchronize the Unfolded Protein Response in Cell Populations In Vivo |
|
|
143 | (20) |
|
|
|
144 | (2) |
|
2 Variable Functions of CHOP in the PERK Signaling Pathway |
|
|
146 | (1) |
|
3 Mutations in the PLP1 Gene: A Model UPR Disease |
|
|
147 | (2) |
|
4 Problems with Current Paradigms Used to Characterize the UPR |
|
|
149 | (1) |
|
5 A Novel In Vivo Genetic Switch Solves Many of These Problems |
|
|
150 | (7) |
|
6 Generalizing GST to Study Other UPR Diseases |
|
|
157 | (1) |
|
|
157 | (1) |
|
|
158 | (5) |
|
10 Glycoprotein Maturation and the UPR |
|
|
163 | (20) |
|
|
|
|
|
163 | (2) |
|
|
165 | (10) |
|
|
175 | (6) |
|
|
181 | (1) |
|
|
181 | (2) |
|
11 Monitoring and Manipulating Mammalian Unfolded Protein Response |
|
|
183 | (16) |
|
|
|
|
|
184 | (1) |
|
2 Monitoring Mammalian UPR |
|
|
185 | (4) |
|
3 Chemical-Genetic Manipulation of Mammalian UPR |
|
|
189 | (5) |
|
|
194 | (1) |
|
|
195 | (1) |
|
|
195 | (4) |
|
12 A Screen for Mutants Requiring Activation of the Unfolded Protein Response for Viability |
|
|
199 | (18) |
|
|
|
|
200 | (2) |
|
2 Screening for Mutants That Require UPR Activation for Viability |
|
|
202 | (7) |
|
3 Cloning and Sequencing per Genes |
|
|
209 | (3) |
|
4 Monitoring the LPR Activity |
|
|
212 | (1) |
|
|
213 | (1) |
|
|
214 | (1) |
|
|
214 | (1) |
|
|
215 | (1) |
|
|
215 | (2) |
|
13 Signaling Pathways of Proteostasis Network Unrevealed by Proteomic Approaches on the Understanding of Misfolded Protein Rescue |
|
|
217 | (18) |
|
|
|
|
|
218 | (1) |
|
2 2DE-Based Proteomics Approach Analysis to Study Protein Expression Profile |
|
|
219 | (1) |
|
|
220 | (1) |
|
|
221 | (2) |
|
5 Protein Identification by MS |
|
|
223 | (2) |
|
|
225 | (1) |
|
7 Data Mining and Publication |
|
|
226 | (5) |
|
|
231 | (1) |
|
|
231 | (4) |
|
14 Decreased Secretion and Unfolded Protein Response Upregulation |
|
|
235 | (26) |
|
|
|
|
|
236 | (1) |
|
2 Heterologous Protein Expression |
|
|
237 | (1) |
|
3 Quality Control Mechanisms of the Secretory Pathway |
|
|
238 | (1) |
|
4 Endoplasmic Reticulum Export and Trafficking |
|
|
239 | (1) |
|
5 Experimental Systems to Evaluate Expression, UPR, and Secretory Processing |
|
|
239 | (1) |
|
6 S. cerevisiae Strains Used for Optimal Expression |
|
|
240 | (1) |
|
|
241 | (2) |
|
8 Evaluation of Heterologous Protein Expression |
|
|
243 | (5) |
|
9 Statistical Analysis of Microarray Results |
|
|
248 | (9) |
|
|
257 | (1) |
|
|
257 | (4) |
|
15 Measuring Signaling by the Unfolded Protein Response |
|
|
261 | (32) |
|
|
|
|
|
|
|
|
262 | (4) |
|
2 Methods to Induce the UPR |
|
|
266 | (1) |
|
3 Measuring Signaling by the UPR in S. cerevisiae |
|
|
266 | (10) |
|
4 Measuring Signaling by the UPR in Mammalian Cells |
|
|
276 | (12) |
|
|
288 | (1) |
|
|
289 | (4) |
|
16 Quantitative Measurement of Events in the Mammalian Unfolded Protein Response |
|
|
293 | (16) |
|
|
|
294 | (1) |
|
2 Cell Culture and ER Stress Inducers |
|
|
295 | (1) |
|
3 Northern Blots for GRP78/BiP and EDEM |
|
|
296 | (3) |
|
4 RT-PCR Analysis of XBP1 mRNA Splicing |
|
|
299 | (3) |
|
5 Immunoblotting and Measurement of ATF6 |
|
|
302 | (1) |
|
6 Measurement of Inhibition of Protein Synthesis |
|
|
302 | (1) |
|
7 Measurement of Stimulation of LLO Extension |
|
|
303 | (1) |
|
8 Calculations of Transcript Accumulation, Signal Activation, and Correlation |
|
|
304 | (1) |
|
|
305 | (1) |
|
|
306 | (1) |
|
|
306 | (3) |
|
17 Regulation of Immunoglobulin Synthesis, Modification, and Trafficking by the Unfolded Protein Response: A Quantitative Approach |
|
|
309 | (18) |
|
|
|
|
310 | (2) |
|
2 Isolation of Splenic B Cells and Infection Thereof by Retroviruses |
|
|
312 | (4) |
|
3 Measurement of Protein Synthesis in Plasma Cells |
|
|
316 | (4) |
|
4 Measurement of Ig Mislocalization in Primary B Cells |
|
|
320 | (4) |
|
|
324 | (1) |
|
|
324 | (3) |
|
18 Use of Chemical Genomics in Assessment of the UPR |
|
|
327 | (16) |
|
|
|
|
328 | (1) |
|
2 Assessment of the Activation of UPR Transcriptional Program in Cancer Cell |
|
|
329 | (5) |
|
3 Gene Expression Signature-Based Identification of UPR Modulators |
|
|
334 | (4) |
|
4 Future Perspective of Chemical Genomics in UPR Research |
|
|
338 | (1) |
|
|
339 | (1) |
|
|
339 | (4) |
|
19 Small GTPase Signaling and the Unfolded Protein Response |
|
|
343 | (18) |
|
|
|
|
|
|
344 | (2) |
|
|
346 | (2) |
|
3 Monitoring the Unfolded Protein Response |
|
|
348 | (5) |
|
4 Monitoring Small GTPase Activity |
|
|
353 | (3) |
|
5 Pharmacological and Genetic Modulation of UPR and GTPase Signaling |
|
|
356 | (2) |
|
|
358 | (1) |
|
|
358 | (3) |
|
20 Inhibitors of Advanced Glycation and Endoplasmic Reticulum Stress |
|
|
361 | (20) |
|
|
|
362 | (1) |
|
2 Advanced Glycation and Its Pathophysiology |
|
|
363 | (1) |
|
3 Measurement of Advanced Glycation |
|
|
364 | (5) |
|
4 Link Between Advanced Glycation and ER Stress |
|
|
369 | (4) |
|
5 Effects of Advanced Glycation Inhibitor Against ER Stress |
|
|
373 | (4) |
|
|
377 | (1) |
|
|
377 | (1) |
|
|
377 | (4) |
Author Index |
|
381 | (18) |
Subject Index |
|
399 | |